Streetbeat News

Earnings

SHCR

Sharecare (NASDAQ:SHCR) is expected to report a Q4 earnings per share (EPS) of $-0.06 on March 28, 2024. Analysts and investors will be looking for an earnings beat and positive guidance for future growth. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat followed by a 1.92% drop. Sharecare's stock has declined 39.73% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:02 pm

HUT

Hut 8 Mining (NASDAQ:HUT) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.25. Investors are hopeful for a beat on this estimate and positive guidance for future growth. Hut 8 Mining's stock performance has been generally positive over the last year, with a 10.34% increase, trading at $9.88 as of March 26. Past earnings have shown varied impacts on stock price, highlighting the importance of guidance alongside earnings results.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

VUZI

Vuzix (NASDAQ:VUZI) is scheduled to release its quarterly earnings report on March 28, 2024, with an expected EPS of $-0.15. The company's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant share price drops the following day. Over the last year, Vuzix shares have decreased by 67.95%, indicating a negative trend for long-term shareholders. Investors are looking for a beat on the EPS estimate and positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

PL

Planet Labs (NYSE:PL) is scheduled to release its quarterly earnings report on March 28, 2024, with an expected EPS of $-0.06. Analysts and investors are particularly interested in the company's guidance for future growth. Historical data shows that Planet Labs' stock price is sensitive to earnings performance and guidance, with a notable 5.45% drop after last quarter's earnings miss. Over the past year, PL shares have declined by 30.29%, indicating a challenging period for the company.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

GROY

Gold Royalty (AMEX:GROY) is scheduled to release its quarterly earnings report on March 28, 2024, with an expected EPS of $-0.01. Despite past earnings misses, the stock price increased following the last report. Shares are currently trading at $1.92, reflecting a 12.39% decrease over the last year. Investors are looking for positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

MSM

MSC Industrial Direct Co (NYSE:MSM) is scheduled to release its quarterly earnings report on 2024-03-28, with analysts expecting an EPS of $1.16. The company's past earnings performance shows mixed results, with a miss last quarter leading to a slight share price drop. Shares have risen 70.78% over the last 52 weeks, indicating positive long-term shareholder sentiment. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

ATAT

Atour Lifestyle Holdings (NASDAQ:ATAT) is scheduled to release its quarterly earnings report on March 28, 2024. Analysts predict an EPS of $0.19. The company's past performance shows mixed results with actual EPS often beating estimates but with varying stock price reactions. Shares are currently trading at $19.18, down 19.7% over the last year. Investors are keen on both the earnings outcome and the company's future guidance.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

AZUL

Azul (NYSE:AZUL) is scheduled to release its quarterly earnings report on March 28, 2024, with an estimated EPS of $0.14. Analysts and investors are keen on whether Azul will surpass this estimate and provide positive guidance for the next quarter. Azul's past earnings performance shows a pattern of not meeting EPS estimates, leading to significant price changes. Shares of Azul have increased by 19.3% over the last 52 weeks, trading at $8.4 as of March 26.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

DARE

Dare Bioscience (NASDAQ:DARE) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.10. Historical data shows mixed reactions to past earnings, with a slight increase in share price following the last quarter's beat. Shares have declined 51.35% over the last year, indicating potential concern among long-term investors ahead of this release.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm

AGRX

Agile Therapeutics (NASDAQ:AGRX) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.92. The company's past earnings performance shows a pattern of beating EPS estimates but experiencing subsequent share price drops. Over the last year, AGRX shares have declined by 96.87%, indicating a bearish outlook among long-term shareholders.

Portfolio Pulse from Benzinga Insights

March 27, 2024 | 2:01 pm